Only recently available on the US market, levocetirizine has emerged as an effective new option in the treatment of chronic idiopathic urticaria (CIU). Levocetirizine is the active isomer of cetirizine and demonstrates twice the affinity for the H1 receptor compared with the parent compound. In the treatment of CIU, levocetirizine has consistently demonstrated high response rates, fast onset, and a favorable side effect profile.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
chronic idiopathic
8
idiopathic urticaria
8
ciu levocetirizine
8
levocetirizine
4
levocetirizine chronic
4
urticaria review
4
review market
4
market levocetirizine
4
levocetirizine emerged
4
emerged effective
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!